LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2021

Mar 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2021-03-12

Reporting Person: Kimball Dawn (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-12	Common Stock	A	5000	$12.09	Acquired	5000	Direct
2021-03-12	Common Stock	D	2644	$12.09	Disposed	2356	Direct
2021-03-12	Common Stock	A	13608	$12.09	Acquired	15964	Direct
2021-03-12	Common Stock	D	6535	$12.09	Disposed	9429	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-12	Restricted Stock Unit	$	M	5000	Disposed	2021-03-12	Common Stock (5000)	Direct
2021-03-12	Restricted Stock Unit	$	M	13608	Disposed	2021-03-12	Common Stock (13608)	Direct

Footnotes

F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2: The restricted stock units were granted on October 12, 2018.

F3: Vesting of restricted stock units was accelerated on March 12, 2021 by reason of Separation Agreement.

F4: The restricted stock units were granted on October 15, 2019.